Skip to Main
Results 1-10 of 14 for "ClinicalTrials.gov NIH helicobacter pylori January 2025 enrollment"

Study implicates another gene in brain that causes weight gain: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/jan-gene-in-brain-that-causes-weight-gain.html

Mutations in a gene called OTP cause obesity by controlling the output of another gene already targeted by an anti-obesity drug, a study led by UT Southwestern Medical Center researchers shows.

UT Southwestern to host virtual discussion on ‘Black Men in White Coats’ documentary: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/black-men-in-white-coats-documentary.html

The importance of increasing the number of Black male doctors in the United States will be the subject of a virtual panel discussion at UT Southwestern in advance of the release of a documentary on the issue.

UT Southwestern announces open enrollment for at-home COLCORONA clinical trial: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/colcorona.html

UT Southwestern Medical Center is the first facility in Dallas and the surrounding region to participate in the international COLCORONA trial.

Financial assistance programs improve outcomes for indigent patients with inflammatory bowel disease: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-financial-assistance-programs.html

Patients with inflammatory bowel disease (IBD) who required treatment with biologic therapies and were enrolled in a financial assistance program were less likely to need surgery after starting medication than those not enrolled in a program, a study by UT Southwestern researchers found.

UT Southwestern develops nanotherapeutic to ward off liver cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/nanotherapeutic-to-ward-off-liver-cancer.html?fbclid=IwAR0BcDOWp2UKETuoDkae2IlTo3yQAJ0QALlP2trZNCiZweKoRKBNOeGYBmk

Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver.

UT Southwestern develops nanotherapeutic to ward off liver cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/nanotherapeutic-to-ward-off-liver-cancer.html

Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver.

UTSW cardiologist receives NIH Outstanding Investigator Award: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/january-nih-outstanding-investigator-award.html

UT Southwestern physician-scientist Hesham Sadek, M.D., Ph.D., has received the prestigious National Institutes of Health (NIH) Outstanding Investigator Award to support his ongoing research into mechanisms behind heart regeneration that could lead to treatments for heart failure.

Dallas ISD and UT Southwestern partner to open a new kind of school: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/dallas-isd-and-ut-southwestern-partner.html

Dallas ISD and the UT Southwestern Medical Center (UTSW) together will launch a new transformation school slated to open its doors next fall.

Clinical trial shows stereotactic radiation extends systemic therapy and slows kidney cancer progression : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/stereotactic-radiation-extends-systemic-therapy.html

A new study by the Kidney Cancer Program (KCP) at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center shows that highly focused radiation to isolated metastases that progress despite drug therapy can prolong drug use in kidney cancer patients, saving the few other drugs for treating

UT Southwestern biochemist, molecular biologist to receive HHMI Emerging Pathogens awards: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/january-hhmi-emerging-pathogens-initiative-grants.html

Research teams led by two UT Southwestern Medical Center faculty members have been selected to receive competitive awards from the Howard Hughes Medical Institute’s (HHMI) Emerging Pathogens Initiative (EPI).